Researchers dig into records to see if new IV platform is safe
NCT ID NCT07609069
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks back at the medical records of 625 people who received an experimental IV drug delivery system. The goal is to see what side effects happened during or after the infusion and whether anyone had to stop treatment early because of them. No new treatments or visits are involved—just a review of past data.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
PICO IV Central Data Coordinating Center
Sacramento, California, 95811, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Weight-Loss drugs may cause hidden anal issues, new study warns
- Can spirulina and fish oil tame immunotherapy lung side effects?
- Gene test may predict dangerous side effects in breast cancer treatment
- Unlicensed cord blood units under safety spotlight in new trial
- Nurse phone calls may keep breast cancer patients safer on targeted therapy
- Prostate cancer Treatment's heart risks under the microscope